(Total Views: 145)
Posted On: 08/20/2020 4:05:50 PM
Post# of 27277
$CYDY News Article - After Several Months of Providing Requested Information About Manufacturing and Safety of Leronlimab, U.K.'s MHRA Accepts CytoDyn's Request to Enroll in its Current Phase 3 Trial for COVID-19 Patients with Severe-to-Critical Symptoms https://marketwirenews.com/news-releases/afte...37985.html
(0)
(0)
My Twitter: WhyteStocks
